Abstract
Although hematopoietic stem cells (HSC) are the best characterized and the most clinically used adult stem cells, efforts are still needed to understand how to best ex vivo expand these cells. Here we present our unexpected finding that OCT4 is involved in the enhancement of cytokine-induced expansion capabilities of human cord blood (CB) HSC. Activation of OCT4 by Oct4-activating compound 1 (OAC1) in CB CD34+ cells enhanced ex vivo expansion of HSC, as determined by a rigorously defined set of markers for human HSC, and in vivo short-term and long-term repopulating ability in NSG mice. Limiting dilution analysis revealed that OAC1 treatment resulted in 3.5-fold increase in the number of SCID repopulating cells (SRCs) compared with that in day 0 uncultured CD34+ cells and 6.3-fold increase compared with that in cells treated with control vehicle. Hematopoietic progenitor cells, as assessed by in vitro colony formation, were also enhanced. Furthermore, we showed that OAC1 treatment led to OCT4-mediated upregulation of HOXB4. Consistently, siRNA-mediated knockdown of HOXB4 expression suppressed effects of OAC1 on ex vivo expansion of HSC. Our study has identified the OCT4-HOXB4 axis in ex vivo expansion of human CB HSC.
Similar content being viewed by others
References
Ballen KK, Gluckman E, Broxmeyer HE . Umbilical cord blood transplantation: the first 25 years and beyond. Blood 2013; 122: 491–498.
Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828–3832.
Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.
Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010; 329: 1345–1348.
Fares I, Chagraoui J, Gareau Y, Gingras S, Ruel R, Mayotte N et al. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 2014; 345: 1509–1512.
Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95: 379–391.
Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122: 947–956.
Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–676.
Szabo E, Rampalli S, Risueno RM, Schnerch A, Mitchell R, Fiebig-Comyn A et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010; 468: 521–526.
Li W, Tian E, Chen ZX, Sun G, Ye P, Yang S et al. Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proc Natl Acad Sci USA 2012; 109: 20853–20858.
Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE . Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005; 26: 495–502.
Goolsby J, Marty MC, Heletz D, Chiappelli J, Tashko G, Yarnell D et al. Hematopoietic progenitors express neural genes. Proc Natl Acad Sci USA 2003; 100: 14926–14931.
Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells (Dayton, Ohio) 2005; 23: 1105–1112.
Liu Y, Hangoc G, Campbell TB, Goodman M, Tao W, Pollok K et al. Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells. Exp Hematol 2008; 36: 947–956.
Rohrabaugh SL, Campbell TB, Hangoc G, Broxmeyer HE . Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice. Blood Cells Mol Dis 2011; 46: 318–320.
Lee MR, Prasain N, Chae HD, Kim YJ, Mantel C, Yoder MC et al. Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells (Dayton, Ohio) 2013; 31: 666–681.
Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007; 448: 553–560.
Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE . Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011; 333: 218–221.
Broxmeyer HE, Lee MR, Hangoc G, Cooper S, Prasain N, Kim YJ et al. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 2011; 117: 4773–4777.
Antonchuk J, Sauvageau G, Humphries RK . HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 2002; 109: 39–45.
Lee J, Shieh JH, Zhang J, Liu L, Zhang Y, Eom JY et al. Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL4-mediated degradation of HOXB4. Blood 2013; 121: 4082–4089.
Zon LI . Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 2008; 453: 306–313.
Dahlberg A, Delaney C, Bernstein ID . Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 2011; 117: 6083–6090.
Povinelli BJ, Nemeth MJ . Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells (Dayton, Ohio) 2014; 32: 105–115.
Zhang CC, Kaba M, Ge G, Xie K, Tong W, Hug C et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med 2006; 12: 240–245.
Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, Gokhale S et al. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 2007; 1: 403–415.
Han SH, Jang G, Bae BK, Han SM, Koh YR, Ahn JO et al. Effect of ectopic OCT4 expression on canine adipose tissue-derived mesenchymal stem cell proliferation. Cell Biol Int 2014; 38: 1163–1173.
Han SM, Han SH, Coh YR, Jang G, Chan Ra J, Kang SK et al. Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells. Exp Mol Med 2014; 46: e101.
Kyba M, Perlingeiro RC, Daley GQ . HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002; 109: 29–37.
Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G . In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med 2003; 9: 1428–1432.
Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Kogler G . Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 2007; 1: 364–366.
Chaurasia P, Gajzer DC, Schaniel C, D'Souza S, Hoffman R . Epigenetic reprogramming induces the expansion of cord blood stem cells. J Clin Invest 2014; 124: 2378–2395.
Acknowledgements
We sincerely thank other lab members in Dr Broxmeyer's laboratory for helpful discussion. This work was supported by Public Health Service Grants from the NIH to HEB: R01 HL056416, R01 HL67384, R01 HL112669 and NIH P01 DK090948. The teratoma study was supported by grant HI14C3365 from the Ministry for Health & Welfare by the Korean government.
Author contributions
XH and HEB directed the research, designed and performed experiments, interpreted data and wrote the manuscript. SC and GH performed experiments and interpreted data. ML, KH and HC performed the teratoma study and interpreted data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
HEB is a member of the Medical Scientific Advisory Board of CordUse, a cord blood banking company based in Orlando, Florida.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Huang, X., Lee, MR., Cooper, S. et al. Activation of OCT4 enhances ex vivo expansion of human cord blood hematopoietic stem and progenitor cells by regulating HOXB4 expression. Leukemia 30, 144–153 (2016). https://doi.org/10.1038/leu.2015.189
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2015.189
- Springer Nature Limited
This article is cited by
-
Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids
Clinical Epigenetics (2021)
-
HOXB4 promotes the malignant progression of ovarian cancer via DHDDS
BMC Cancer (2020)
-
Cord blood research, banking, and transplantation: achievements, challenges, and perspectives
Bone Marrow Transplantation (2020)
-
An Overview of Novel Unconventional Mechanisms of Hematopoietic Development and Regulators of Hematopoiesis – a Roadmap for Future Investigations
Stem Cell Reviews and Reports (2019)
-
Human Hematopoietic Stem Cells: Concepts and Perspectives on the Biology and Use of Fresh Versus In Vitro–Generated Cells for Therapeutic Applications
Current Stem Cell Reports (2019)